You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for South Africa Patent: 200707469


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Africa Patent: 200707469

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,815,942 Aug 27, 2027 Teva AZILECT rasagiline mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Africa Patent ZA200707469

Last updated: August 3, 2025

Introduction

Patent ZA200707469, granted in South Africa, relates to a pharmaceutical invention with potential global importance. This analysis provides an exhaustive review of its scope, claims, and the surrounding patent landscape, offering insights for industry stakeholders, patent professionals, and researchers navigating this sector. Such evaluations are critical for strategic decision-making, including licensing, infringement risk assessment, and research direction.


Patent Overview and Filing Context

Patent ZA200707469 was filed in South Africa and granted in 2007. Its filing likely predates broader international application, which may suggest it originates from local inventive activity or is part of a global patent application family. The patent's subject matter, claims, and scope are central to understanding its enforceability and commercial potential within South Africa.


Scope and Claims Analysis

1. Core Invention and Technical Field

The patent's legal focus appears centered on a novel pharmaceutical compound, formulation, or method of treatment—common themes in drug patents. The patent’s scope hinges significantly on the specific claims, which define the legal boundaries of the patent's protection.

2. Main Claims and Their Breadth

  • Independent Claims:
    The core claims likely encompass a compound or composition with a specified structural formula or a particular method of use. Broad claims might cover a class of compounds or treatment methods, offering extensive protection. Narrower claims might define specific analogs, dosages, or delivery mechanisms.

  • Dependent Claims:
    These elaborate on the independent claims, specifying particular embodiments, formulations, or use cases. Such claims can serve to reinforce the patent's scope while also providing fallback positions for infringement disputes.

3. Scope of Protection

  • Chemical Scope:
    If the patent claims a class of compounds, its scope depends on the language's breadth—whether it covers all derivatives within a chemical class or is limited to specific compounds.

  • Method of Treatment:
    Claims related to methods of administering or using the compound may extend the patent's coverage to particular therapeutic protocols, impacting clinical research and generics' entry.

  • Formulation and Delivery:
    Claims on specific formulations or delivery devices (e.g., sustained-release, injection) provide granularity, but narrow their enforceability to those variants.

4. Scope Limitations and Potential Challenges

  • Clarity and Enablement:
    South African patent law emphasizes sufficient disclosure and clarity. If the claims or description lack precision, the patent may face validity challenges.

  • Polymer and Patent Class:
    Its classification under medicinal or chemical patent classes can influence the scope and ease of prior art searches.

  • Claim Construction:
    The specific language used, including terms like "comprising," "consisting of," or "having," affects the interpretative breadth.


Patent Landscape

1. National and International Patent Families

  • Global Family:
    It’s common for pharmaceutical inventions to be filed via patent families in multiple jurisdictions, including Europe, the US, and WIPO PCT applications. The strategic filing impact, especially in South Africa, references the regional or international coverage.

  • Relation to Other Patents:
    Evaluating prior art and subsequent patents reveals the innovation’s novelty status and infringement risks.

2. Competitor and Infringing Patent Activities

  • Active Patent Filings:
    Companies operating within South Africa or targeting the same therapeutic area may have filed similar or blocking patents.

  • Patent Thickets:
    A dense landscape can pose barriers for generic entry or new research; understanding overlapping patents informs these risks.

  • Patent Expiry:
    The patent's term (generally 20 years from filing) and any extensions or national phases influence market exclusivity.

3. Regional Patent Strategies and Coverage

  • South Africa's Patent Environment:
    South Africa's patent system emphasizes novelty, inventive step, and industrial applicability. The country has a relatively active pharmaceutical patent landscape and is a member of WIPO, facilitating regional patent protections.

  • Harmonization Efforts:
    Regional treaties (ARIPO, OAPI) may influence how this patent interacts with neighboring jurisdictions.


Legal and Commercial Implications

  • Enforceability:
    The validity of the patent depends on its compliance with local patentability requirements—novelty, inventive step, and sufficiently clear disclosure.

  • Freedom-to-Operate (FTO):
    Analyzed through the scope of claims and the patent landscape to assess risks of infringement.

  • Market Strategies:
    Patent protection duration, scope breadth, and potential for licensing or settlement, are vital for commercialization.


Conclusion

Patent ZA200707469 broadly claims a pharmaceutical invention, possibly covering a class of compounds and/or therapeutic methods. Its scope depends significantly on claim language, which appears tailored for both broad protection and specific embodiments. The patent landscape within South Africa involves consideration of similar filings, potential patent thickets, and the patent’s enforceability.

Given South Africa's active pharmaceutical patent environment, strategic patent management—addressing validity, infringement risks, and licensing—remains critical for stakeholders. This patent’s protection likely influences drug commercialization, research pathways, and competition within the regional market.


Key Takeaways

  • Claims Breadth: Clear, comprehensive claims enhance enforceability but must be balanced against prior art to avoid invalidation.

  • Patent Landscape Awareness: A thorough landscape analysis identifies potential patent barriers and licensing opportunities, crucial for market entry or expansion.

  • Local Patent Law Nuances: South Africa’s patent standards demand explicit disclosures and inventive activity, influencing patent validity.

  • Global Patent Strategies: Filing in multiple jurisdictions can extend protection but involves strategic considerations of costs and jurisdiction-specific patent laws.

  • Ongoing Monitoring: Continuous surveillance for new patent filings related to the invention maintains competitive advantage and mitigates infringement risks.


FAQs

1. What is the significance of patent claims in pharmaceutical patents?
Claims define the scope of legal protection. Broad claims can cover extensive variations, while narrow claims specify particular embodiments. Clear, well-drafted claims strengthen enforceability and influence market leverage.

2. How does South Africa's patent landscape affect drug patent holders?
South Africa enforces patent law requiring novelty and inventive step, with an active pharmaceutical patent environment that necessitates strategic patent filings, vigilance against infringing patents, and careful navigation of licensing negotiations.

3. Can a patent like ZA200707469 be challenged or overturned?
Yes, through invalidation proceedings based on prior art, insufficient disclosure, or lack of inventive step. The strength of its claims and prior art searches influence its robustness.

4. How does this patent interact with international patent rights?
It may be part of a broader patent family protected through PCT or regional filings, facilitating global market protection and strategic licensing options.

5. What should companies consider before launching a generic drug based on this patent?
They must evaluate the patent's validity, claims scope, potential patent expirations, and whether any invalidity defenses or licensing opportunities exist within South Africa.


References

  1. South African Patent Office. Patent laws and guidelines.
  2. World Intellectual Property Organization (WIPO). Patent landscape reports.
  3. Recent publications on South African pharmaceutical patent jurisprudence.
  4. Specific patent document analysis databases and prior art references, where accessible.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.